Yuanfeng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuanfeng Zhang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Jinming Li
National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China
6 shared publications - Rui Zhang
National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, P. R. China
6 shared publications - Leming Shi
Fudan University, China
5 shared publications - Yaqing Liu
State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China
5 shared publications - Ying Yu
State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China
5 shared publications - Yuanting Zheng
State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China
5 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Benchmarking RNA-seq with the Quartet and MAQC reference materials to establish best practices for accurate alternative splicing analysis
Previous limited characterization of short-read RNA-seq (srRNA-seq) accuracy in alternative splicing (AS) analysis due to methodological diversity and lack of reference standards, has left unclear how to achieve optimal performance—an issue increasingly critical with the rise of long-read sequencing. To address this, we conduct a large-scale reference-based benchmarking study across 42 laboratories and 207 analysis pipelines leveraging the Quartet and MAQC reference materials. Here, we show that high data quality and depth improved the accuracy of splice junction detection, as well as isoform- and event-level quantification and differential analysis. Best practices for experimental and bioinformatic design are identified, with optimal pipelines achieving Pearson and Matthews correlation coefficients of 0.79 and 0.68 for isoform-level quantification and differential analysis, and 0.41 and 0.41 for event-level analyses, respectively. This corresponds to improvements of 0.21–0.45 and 0.51–0.67 at the isoform level, and 0.09–0.27 and 0.16–0.34 at the event level relative to the poorest-performing pipelines across laboratories. Beyond technical workflows, low expression or coverage and high compositional complexity represent general constraints on accuracy. Collectively, this study provides practical guidance for maximizing AS profiling accuracy with existing methodologies, contributing to effective srRNA-seq application in RNA splicing research.
- 8 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessBenchmarking RNA-seq with the Quartet and MAQC reference materials to establish best practices for accurate alternative splicing analysis
Previous limited characterization of short-read RNA-seq (srRNA-seq) accuracy in alternative splicing (AS) analysis due to methodological diversity and lack of reference standards, has left unclear how to achieve optimal performance—an issue increasingly critical with the rise of long-read sequencing. To address this, we conduct a large-scale reference-based benchmarking study across 42 laboratories and 207 analysis pipelines leveraging the Quartet and MAQC reference materials. Here, we show that high data quality and depth improved the accuracy of splice junction detection, as well as isoform- and event-level quantification and differential analysis. Best practices for experimental and bioinformatic design are identified, with optimal pipelines achieving Pearson and Matthews correlation coefficients of 0.79 and 0.68 for isoform-level quantification and differential analysis, and 0.41 and 0.41 for event-level analyses, respectively. This corresponds to improvements of 0.21–0.45 and 0.51–0.67 at the isoform level, and 0.09–0.27 and 0.16–0.34 at the event level relative to the poorest-performing pipelines across laboratories. Beyond technical workflows, low expression or coverage and high compositional complexity represent general constraints on accuracy. Collectively, this study provides practical guidance for maximizing AS profiling accuracy with existing methodologies, contributing to effective srRNA-seq application in RNA splicing research.
- Open Access
- 5 November 2025
- Published by Springer Nature in Research Square
Benchmarking RNA-seq with the Quartet Reference Materials to establish Best Practices for Accurate Alternative Splicing Detection
Previous limited characterization of RNA-seq accuracy in alternative splicing (AS) due to methodological diversity and lack of reference standards has left unclear how to achieve optimal performance for informed applications—an issue increasingly critical with the rise of long-read sequencing. To address this, we conducted the first large-scale reference-based benchmarking of AS detection accuracy across 42 laboratories and 159 analysis pipelines, leveraging the Quartet reference materials. We show that high-quality RNA-seq enables relatively accurate isoform detection. Best practices for experimental and bioinformatic designs were identified, and achieved mean Pearson correlations of 0.82 for isoform quantification and Matthews correlation coefficients of 0.69 for differential expression analysis, representing improvements of 0.21–0.31 and 0.46–0.61 across laboratories, respectively, compared to the poorest workflows. AS event-level accuracy remained limited, yet the best tools still outperformed the poorest by 0.02–0.25 in event quantification and 0.10–0.25 in differential splicing analysis. Beyond technical variables, low expression levels were the primary constraint on isoform and event detection accuracy, followed by their compositional complexity. Collectively, this study provides practical guidance for maximizing AS profiling accuracy with existing methodologies, contributing to effective RNA-seq application in splicing research.
- 5 November 2025
- Published by Springer Nature in Research Square
Open AccessBenchmarking RNA-seq with the Quartet Reference Materials to establish Best Practices for Accurate Alternative Splicing Detection
Previous limited characterization of RNA-seq accuracy in alternative splicing (AS) due to methodological diversity and lack of reference standards has left unclear how to achieve optimal performance for informed applications—an issue increasingly critical with the rise of long-read sequencing. To address this, we conducted the first large-scale reference-based benchmarking of AS detection accuracy across 42 laboratories and 159 analysis pipelines, leveraging the Quartet reference materials. We show that high-quality RNA-seq enables relatively accurate isoform detection. Best practices for experimental and bioinformatic designs were identified, and achieved mean Pearson correlations of 0.82 for isoform quantification and Matthews correlation coefficients of 0.69 for differential expression analysis, representing improvements of 0.21–0.31 and 0.46–0.61 across laboratories, respectively, compared to the poorest workflows. AS event-level accuracy remained limited, yet the best tools still outperformed the poorest by 0.02–0.25 in event quantification and 0.10–0.25 in differential splicing analysis. Beyond technical variables, low expression levels were the primary constraint on isoform and event detection accuracy, followed by their compositional complexity. Collectively, this study provides practical guidance for maximizing AS profiling accuracy with existing methodologies, contributing to effective RNA-seq application in splicing research.
- Open Access
- 16 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Methylation reference datasets from quartet DNA materials for benchmarking epigenome sequencing
The lack of quantitative methylation reference datasets (ground truth) and cross-laboratory reproducibility assessment hinders clinical translation of epigenome-wide sequencing technologies. Using certified Quartet DNA reference materials, here we generate 108 epigenome-sequencing datasets across three mainstream protocols (whole-genome bisulfite sequencing, enzymatic methyl-seq, and TET-assisted pyridine borane sequencing) with triplicates per sample across laboratories. We observe strand-specific methylation biases across all protocols and libraries. Cross-laboratory reproducibility analyses reveal high quantitative methylation levels agreement (mean Pearson correlation coefficient (PCC) = 0.96) but low detection concordance (mean Jaccard index = 0.36). Using consensus voting, we construct genome-wide quantitative methylation reference datasets serving as ground truth for proficiency testing. Key technical parameters–including mean CpG depth, coverage, and strand consistency–correlate strongly with reference-dependent quality metrics (recall, PCC, and RMSE). Collectively, these resources establish foundational standards for benchmarking emerging epigenomic technologies and analytical pipelines, enabling robust, standardized quality control in research and clinical applications.
- 16 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessMethylation reference datasets from quartet DNA materials for benchmarking epigenome sequencing
The lack of quantitative methylation reference datasets (ground truth) and cross-laboratory reproducibility assessment hinders clinical translation of epigenome-wide sequencing technologies. Using certified Quartet DNA reference materials, here we generate 108 epigenome-sequencing datasets across three mainstream protocols (whole-genome bisulfite sequencing, enzymatic methyl-seq, and TET-assisted pyridine borane sequencing) with triplicates per sample across laboratories. We observe strand-specific methylation biases across all protocols and libraries. Cross-laboratory reproducibility analyses reveal high quantitative methylation levels agreement (mean Pearson correlation coefficient (PCC) = 0.96) but low detection concordance (mean Jaccard index = 0.36). Using consensus voting, we construct genome-wide quantitative methylation reference datasets serving as ground truth for proficiency testing. Key technical parameters–including mean CpG depth, coverage, and strand consistency–correlate strongly with reference-dependent quality metrics (recall, PCC, and RMSE). Collectively, these resources establish foundational standards for benchmarking emerging epigenomic technologies and analytical pipelines, enabling robust, standardized quality control in research and clinical applications.
- Open Access
- 9 May 2025
- Published by Springer Nature in Research Square
Quantitative methylation reference datasets of Quartet DNA reference materials for benchmarking genome-wide epigenome sequencing
The absence of cross-lab and cross-replicate reproducibility assessments and the lack of quantitative methylation reference datasets (ground truth) impedes benchmarking genome-wide epigenome sequencing for its intended use in clinical settings such as disease diagnostics and prognostics. Using the four Quartet DNA reference materials, we generated cross-lab epigenome sequencing datasets with three technical replicates per sample using three mainstream protocols, including whole-genome bisulfite sequencing, enzymatic methyl-seq, and TET-assisted pyridine borane sequencing. We found profound strand biases in methylation quantification in each library across all protocols. Cross-lab and cross-replicate reproducibility analyses showed low qualitative concordance of detection (mean Jaccard index = 0.36) yet high quantitative agreement of methylation levels (mean Pearson correlation coefficient = 0.96) in overlapping CpG sites. Then, we constructed genome-wide reference datasets using consensus voting, providing ground truth for cross-protocol and cross-lab proficiency tests. Additionally, we revealed that the mean CpG depth, coverage, and strand consistency highly correlate with the reference datasets-dependent quality metrics. The Quartet DNA reference materials and genome-wide quantitative methylation reference datasets provide foundational benchmarks for epigenome sequencing, enabling standardized quality assessment of emerging epigenomic technologies and analytical pipelines.
- 9 May 2025
- Published by Springer Nature in Research Square
Open AccessQuantitative methylation reference datasets of Quartet DNA reference materials for benchmarking genome-wide epigenome sequencing
The absence of cross-lab and cross-replicate reproducibility assessments and the lack of quantitative methylation reference datasets (ground truth) impedes benchmarking genome-wide epigenome sequencing for its intended use in clinical settings such as disease diagnostics and prognostics. Using the four Quartet DNA reference materials, we generated cross-lab epigenome sequencing datasets with three technical replicates per sample using three mainstream protocols, including whole-genome bisulfite sequencing, enzymatic methyl-seq, and TET-assisted pyridine borane sequencing. We found profound strand biases in methylation quantification in each library across all protocols. Cross-lab and cross-replicate reproducibility analyses showed low qualitative concordance of detection (mean Jaccard index = 0.36) yet high quantitative agreement of methylation levels (mean Pearson correlation coefficient = 0.96) in overlapping CpG sites. Then, we constructed genome-wide reference datasets using consensus voting, providing ground truth for cross-protocol and cross-lab proficiency tests. Additionally, we revealed that the mean CpG depth, coverage, and strand consistency highly correlate with the reference datasets-dependent quality metrics. The Quartet DNA reference materials and genome-wide quantitative methylation reference datasets provide foundational benchmarks for epigenome sequencing, enabling standardized quality assessment of emerging epigenomic technologies and analytical pipelines.
- Open Access
- 22 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-21
A real-world multi-center RNA-seq benchmarking study using the Quartet and MAQC reference materials
Translating RNA-seq into clinical diagnostics requires ensuring the reliability and cross-laboratory consistency of detecting clinically relevant subtle differential expressions, such as those between different disease subtypes or stages. As part of the Quartet project, we present an RNA-seq benchmarking study across 45 laboratories using the Quartet and MAQC reference samples spiked with ERCC controls. Based on multiple types of ‘ground truth’, we systematically assess the real-world RNA-seq performance and investigate the influencing factors involved in 26 experimental processes and 140 bioinformatics pipelines. Here we show greater inter-laboratory variations in detecting subtle differential expressions among the Quartet samples. Experimental factors including mRNA enrichment and strandedness, and each bioinformatics step, emerge as primary sources of variations in gene expression. We underscore the profound influence of experimental execution, and provide best practice recommendations for experimental designs, strategies for filtering low-expression genes, and the optimal gene annotation and analysis pipelines. In summary, this study lays the foundation for developing and quality control of RNA-seq for clinical diagnostic purposes.
- 22 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-21
Open AccessA real-world multi-center RNA-seq benchmarking study using the Quartet and MAQC reference materials
Translating RNA-seq into clinical diagnostics requires ensuring the reliability and cross-laboratory consistency of detecting clinically relevant subtle differential expressions, such as those between different disease subtypes or stages. As part of the Quartet project, we present an RNA-seq benchmarking study across 45 laboratories using the Quartet and MAQC reference samples spiked with ERCC controls. Based on multiple types of ‘ground truth’, we systematically assess the real-world RNA-seq performance and investigate the influencing factors involved in 26 experimental processes and 140 bioinformatics pipelines. Here we show greater inter-laboratory variations in detecting subtle differential expressions among the Quartet samples. Experimental factors including mRNA enrichment and strandedness, and each bioinformatics step, emerge as primary sources of variations in gene expression. We underscore the profound influence of experimental execution, and provide best practice recommendations for experimental designs, strategies for filtering low-expression genes, and the optimal gene annotation and analysis pipelines. In summary, this study lays the foundation for developing and quality control of RNA-seq for clinical diagnostic purposes.
- Open Access
- 23 January 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-13
Enhancing the quality of panel-based tumor mutation burden assessment: a comprehensive study of real-world and in-silico outcomes
Targeted panel-based tumor mutation burden (TMB) assays are widely employed to guide immunotherapy for patients with solid tumors. However, the accuracy and consistency of this method can be compromised due to the variability in technical details across different laboratories, particularly in terms of panel size, somatic mutation detection and TMB calculation rules. Currently, systematic evaluations of the impact of these technical factors on existing assays and best practice recommendations remain lacking. We assessed the performance of 50 participating panel-based TMB assays involving 38 unique methods using cell line samples. In silico experiments utilizing TCGA MC3 datasets were performed to further dissect the impact of technical factors. Here we show that the panel sizes beyond 1.04 Mb and 389 genes are necessary for the basic discrete accuracy, as determined by over 40,000 synthetic panels. The somatic mutation detection should maintain a reciprocal gap of recall and precision less than 0.179 for reliable psTMB calculation results. The inclusion of synonymous, nonsense and hotspot mutations could enhance the accuracy of panel-based TMB assay. A 5% variant allele frequency cut-off is suitable for TMB assays using tumor samples with at least 20% tumor purity. In conclusion, this multicenter study elucidates the major technical factors as sources of variability in panel-based TMB assays and proposed comprehensive recommendations for the enhancement of accuracy and consistency. These findings will assist clinical laboratories in optimizing the methodological details through bioinformatic experiments to enhance the reliability of panel-based methods.
- 23 January 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-13
Open AccessEnhancing the quality of panel-based tumor mutation burden assessment: a comprehensive study of real-world and in-silico outcomes
Targeted panel-based tumor mutation burden (TMB) assays are widely employed to guide immunotherapy for patients with solid tumors. However, the accuracy and consistency of this method can be compromised due to the variability in technical details across different laboratories, particularly in terms of panel size, somatic mutation detection and TMB calculation rules. Currently, systematic evaluations of the impact of these technical factors on existing assays and best practice recommendations remain lacking. We assessed the performance of 50 participating panel-based TMB assays involving 38 unique methods using cell line samples. In silico experiments utilizing TCGA MC3 datasets were performed to further dissect the impact of technical factors. Here we show that the panel sizes beyond 1.04 Mb and 389 genes are necessary for the basic discrete accuracy, as determined by over 40,000 synthetic panels. The somatic mutation detection should maintain a reciprocal gap of recall and precision less than 0.179 for reliable psTMB calculation results. The inclusion of synonymous, nonsense and hotspot mutations could enhance the accuracy of panel-based TMB assay. A 5% variant allele frequency cut-off is suitable for TMB assays using tumor samples with at least 20% tumor purity. In conclusion, this multicenter study elucidates the major technical factors as sources of variability in panel-based TMB assays and proposed comprehensive recommendations for the enhancement of accuracy and consistency. These findings will assist clinical laboratories in optimizing the methodological details through bioinformatic experiments to enhance the reliability of panel-based methods.